Sweden· SE-20201229000015
Exametazim Radiopharmacy Laboratory 0,5 mg Beredningssats för radioaktivt läkemedel
A exametazim product containing exametazime, registered in Sweden by RADIOPHARMACY Laboratory Ltd.. The same ATC class is registered in 2 of our 19 countries.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
Where it is registered
Exametazime is registered in 2 of 19 countries.
Countries holding a registration under ATC Exametazim (exametazim), each read from that country’s own register.
- This record: Sweden, from Swedish Medical Products Agency (Sweden)
- 1 of them publish a price we can compare per daily dose
Exametazime · ATC Exametazim
2 / 19 countries
- Spainprice
- Sweden
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Exametazime
- Manufacturer
- RADIOPHARMACY Laboratory Ltd.
- Country
- Sweden (SE)
- ATC code
- Exametazim
- ATC class
- Exametazim
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20201229000015
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Exametazime in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaEXAMETAZIM RADIOPHARMACY LABORATORIUMRadiopharmacy Laboratorium Kft., Budaörs
- SpainCERETEC 500 MICROGRAMOS EQUIPO DE REACTIVOS PARA PREPARACIÓN RADIOFARMACÉUTICAGe Healthcare Bio-Sciences, S.A.U.
- United KingdomCeretec 500microgram kit for radiopharmaceutical preparationGE Healthcare Ltd
- BelgiumExametazime Radiopharmacy Laboratory 0.5 mgRadiopharmacy Laboratory
- CanadaCERETECGE HEALTHCARE CANADA INC
- NetherlandsCeretec 0,5 mg kit voor radiofarmaceutische preparaatGE Healthcare B.V.
- GermanyMedi-ExametazimRadiopharmacy Laboratórium Kft.
- FinlandCeretecGE Healthcare AS
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Medi-Exametazim
- Belgium · Exametazime Radiopharmacy Laboratory, Stabilised Ceretec
- Czechia · Brain - Spect Kit, Exametazim Radiopharmacy Laboratorium
- Germany · Medi-Exametazim
- Denmark · Ceretec, Medi-Exametazim
- Spain · Ceretec, Ceretec Estabilizado
- Finland · Ceretec
- France · Cerestab, Ceretec
- United Kingdom (Northern Ireland) · Ceretec, Stabilised Ceretec
- Greece · Ceretec
- Hungary · Brain-Spect, Ceretec
- Italy · Ceretec, Exametascan
- Lithuania · Ceretec
- Luxembourg · Medi-Exametazim, Stabilised Ceretec
- Netherlands · Ceretec, Exametazime Radiopharmacy Laboratory
- Norway · Ceretec, Exametazime Radiopharmacy Laboratory
- Portugal · Exametazima Radiopharmacy
- Slovenia · Eksametazim Radiopharmacy Laboratory
- Slovakia · Ceretec
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bff2959f-5089-4501-ae64-f2b67b9c6f1e GET /v1/drugs/bff2959f-5089-4501-ae64-f2b67b9c6f1e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "20201229000015",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20201229000015",
"product_doc_link": "https://docetp.mpa.se/LMF/Exametazim%20Radiopharmacy%20Laboratory%200.5%20mg%20Kit%20for%20radiopharmaceutical%20preparation%20SmPC_09001bee820d5906.pdf"
}See everything about exametazime.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.